You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HGSOC

Showing 1 - 25 of 51
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High Grade Serous Ovarian Cancer (HGSOC) Trial (FAPI PET CT)

Not yet recruiting
  • High Grade Serous Ovarian Cancer (HGSOC)
  • FAPI PET CT
  • (no location specified)
Jul 20, 2023

Ovarian Tumors Trial in Worldwide (Tilvestamab)

Recruiting
  • Ovarian Neoplasms
  • Tilvestamab
  • Seoul, Korea, Republic of
  • +8 more
Jul 19, 2022

Ovarian Carcinoma Trial (PEP-DC1, OC-DC, PEP-DC2)

Not yet recruiting
  • Ovarian Carcinoma
  • PEP-DC1
  • +3 more
  • (no location specified)
Jan 26, 2023

Multi-layer Data to Improve Diagnosis, Predict Therapy

Recruiting
  • High Grade Ovarian Serous Adenocarcinoma
  • WGS and RNA sequencing
  • +2 more
  • Turku, Finland
    Turku University Hospital
Apr 26, 2022

High Grade Serous Adenocarcinoma of Ovary, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial (Sovilnesib)

Not yet recruiting
  • High Grade Serous Adenocarcinoma of Ovary
  • +3 more
  • (no location specified)
Oct 13, 2023

Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

Recruiting
  • Fallopian Tube Carcinosarcoma
  • +28 more
  • Pegylated Liposomal Doxorubicin Hydrochloride
  • Peposertib
  • Aurora, Colorado
  • +7 more
Sep 2, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Melbourne (Atezolizumab, Bevacizumab, Cobimetinib)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Dec 18, 2019

Triple Negative Breast Cancer, Renal Cell Cancer, High Grade Ovarian Serous Adenocarcinoma Trial in United Kingdom

Recruiting
  • Triple Negative Breast Cancer
  • +3 more
  • Modi-1/Modi-1v
  • +2 more
  • Brighton, Default, United Kingdom
  • +13 more
Nov 18, 2022

High Grade Fallopian Tube Serous Adenocarcinoma, High Grade Ovarian Serous Adenocarcinoma, Primary Peritoneal High Grade Serous

Withdrawn
  • High Grade Fallopian Tube Serous Adenocarcinoma
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 22, 2020

High Grade Serous Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Cambridge (Upifitimab rilsodotin,

Recruiting
  • High Grade Serous Ovarian Cancer
  • +2 more
  • Upifitimab rilsodotin
  • Placebo
  • Phoenix, Arizona
  • +40 more
Jan 25, 2023

Variance of HRD From Paired Ovarian Cancer

Not yet recruiting
  • Ovarian Cancer
  • +2 more
    • Nanjing, Jiangsu, China
      Xiaoxiang Chen
    Sep 25, 2021

    High-grade Serous Ovarian Carcinoma, Ovarian Carcinoma Trial in Worldwide (Pembrolizumab, Paclitaxel, Carboplatin)

    Recruiting
    • High-grade Serous Ovarian Carcinoma
    • Ovarian Carcinoma
    • Pembrolizumab
    • +5 more
    • Aurora, Colorado
    • +37 more
    Jan 19, 2023

    Advanced Solid Tumors Trial in Worldwide (AMG 650)

    Active, not recruiting
    • Advanced Solid Tumors
    • AMG 650
    • Los Angeles, California
    • +21 more
    Jan 26, 2023

    Ovarian Cancer Trial in Rome (Tumor and blood sample)

    Recruiting
    • Ovarian Cancer
    • Tumor and blood sample
    • Rome, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Jul 18, 2023

    Ovarian Cancer Trial in Rome (Tumor biopsy)

    Recruiting
    • Ovarian Cancer
    • Tumor biopsy
    • Rome, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Oct 2, 2023

    Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, Endometrial Cancer Trial in Oklahoma City, Houston (AO-252)

    Recruiting
    • Triple Negative Breast Cancer
    • +2 more
    • Oklahoma City, Oklahoma
    • +1 more
    Nov 13, 2023

    Gynecologic Cancer, Ovarian Cancer, High Grade Serous Carcinoma Trial in Ljubljana (Carboplatin)

    Recruiting
    • Gynecologic Cancer
    • +3 more
    • Ljubljana, Slovenia
    • +1 more
    Aug 6, 2022

    Ovarian Cancer Trial in Manchester (Olaparib, Cediranib, Platinum-based Chemotherapy)

    Completed
    • Ovarian Cancer
    • Manchester, United Kingdom
      The Christie NHS Foundation Trust
    Feb 4, 2022

    Endometrioid Cancer, Mucinous Ovarian Cancer, High Grade Serous Ovarian Cancer Trial in Oklahoma City (VS-6766 + defactinib)

    Not yet recruiting
    • Endometrioid Cancer
    • +3 more
    • VS-6766 + defactinib
    • Oklahoma City, Oklahoma
      Stephenson Cancer Center
    Aug 19, 2022

    High-Grade Ovarian Cancer Terms of Homologous Recombination

    Not yet recruiting
    • Ovarian Cancer
    • +2 more
    • Standard of care
    • (no location specified)
    Oct 7, 2022

    Platinum-resistant Epithelial Ovarian Cancer Trial in Ocala, Mineola (Maveropepimut-S, Cyclophosphamide 50mg)

    Recruiting
    • Platinum-resistant Epithelial Ovarian Cancer
    • Maveropepimut-S
    • Cyclophosphamide 50mg
    • Ocala, Florida
    • +1 more
    Jul 20, 2022

    First-line Olaparib Combined With Bevacizumab Maintenance

    Not yet recruiting
    • Ovarian Neoplasms
    • olaparib plus bevacizumab maintenance therapy
    • (no location specified)
    Jun 29, 2022

    Ovarian Tumors, Endometrial Tumors, NSCLC Trial in United Kingdom, United States (SGN-ALPV)

    Recruiting
    • Ovarian Neoplasms
    • +5 more
    • Fresno, California
    • +10 more
    Jan 20, 2023

    New Prognostic Index for Neoadjuvant Chemotherapy Outcome in

    Enrolling by invitation
    • Ovarian Cancer
    • +2 more
    • CRS scoring
    • Routine blood laboratory testing before treatment
    • Guangzhou, Guangdong, China
      The Sun Yat-sen Memorial Hospital of Sun Yat-sen University
    Nov 2, 2023

    Hyperthermic Intraperitoneal Chemo, Neoadjuvant Chemo Trial in Guangzhou (HIPEC, intravenous chemo)

    Recruiting
    • Hyperthermic Intraperitoneal Chemotherapy
    • Neoadjuvant Chemotherapy
    • HIPEC
    • intravenous chemotherapy
    • Guangzhou, Other (Non U.s.), China
      Sun Yat-sen Memorial Hospital
    Feb 17, 2022